Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Regulatory Roundup: FDA approves new heart failure therapy, clears an interventional device and much more

The FDA has been busy this month. Review some of the biggest FDA-related stories of October, including big news from scPharmaceuticals, Abiomed, Bristol Myers Squibb and MedAlliance, in our monthly roundup. 

MRI shows structural, functional brain abnormalities in Lyme disease long-haulers

Compared to a group of patients who had not been previously diagnosed with Lyme disease, those who had been infected displayed unusual activity in the frontal lobe of the brain on functional MRI scans.

Thumbnail

American College of Cardiology shares expert analysis on treating ASCVD patients with multiple chronic conditions

The new guidance document was designed to help cardiologists and other clinicians deliver the best care possible when treating ASCVD patients who present with additional conditions that need to be considered. 

Thumbnail

FDA announces new recall of blood pressure medication due to potential cancer risk

Patients impacted by this recall are advised to speak with a physician about how to proceed. 

Thumbnail

E-cigarettes linked to AFib, other heart rhythm issues in ‘highly concerning’ new study

“The findings of this study are important because they provide fresh evidence that the use of e-cigarettes could interfere with normal heart rhythms—something we did not know before,” according to one specialist. 

Thumbnail

HCA Healthcare slashes contract labor to cut costs

One of the nation’s largest health systems is shoring up its expenses by cutting back on contract labor amid growing financial challenges. 

 

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Cordis to acquire MedAlliance, known for its drug-eluting balloons, in deal that could surpass $1B

The acquisition includes an initial investment of $35 million and an upfront closing payment of $200 million. By 2029, if the companies reach all targeted regulatory and commercial milestones, the acquisition could cost Cordis up to $1.135 billion in all.

Automated, EMR-based screening proves preventive as well as curative

After programming its EMR to automatically order ultrasound screenings for people at risk of abdominal aortic aneurysms (AAAs), a healthcare system saw a 540% spike in monthly screening exams for the condition over a six-year period.